ArticleJournal of the National Cancer Institute2022

Modified Eligibility Criteria: Patient Access and Subpopulation Applicability vs Efficiency in Drug Development.

Peter J O'DwyerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.